+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
Healthy Volunteers
ID07873112

Performance and Safety Evaluation of the MD60000 Intradermal Gel Device for Treating Facial Skin Aging Wrinkles

Led by Promoitalia Group Spa · Updated on 2026-10-14

43

Participants Needed

1

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the performance and safety of the MD60000 medical device, a sterile, biodegradable intradermal gel containing 3.3% linear hyaluronic acid combined with polylactic acid PLA, designed to correct facial skin imperfections caused by aging such as wrinkles. This single-center, uncontrolled, single-arm clinical study aims to gather clinical data to support regulatory conformity under European Medical Device Regulation 2017745. Forty-three adult participants aged 18 to 65 with facial skin defects scoring at least 1 on the Lemperle Wrinkle Severity Scale are enrolled. Participants receive two intradermal injections of MD60000 gel, up to 2 milliliters per session, administered at baseline and approximately 21 days later. The study includes four main visits screening and baseline assessments with photographic documentation and wrinkle evaluation, two treatment sessions, and a follow-up visit 30 days after the second treatment where final assessments and patient satisfaction surveys are completed. The study lasts between 45 and 65 days per participant. Throughout the trial, researchers monitor wrinkle improvement using the Lemperle Wrinkle Severity Scale and patient satisfaction through the Global Aesthetic Improvement Scale GAIS. Safety is carefully assessed by tracking adverse events and device-related effects from the start of treatment through the follow-up. Statistical analysis evaluates both safety and performance outcomes. The total duration for the entire clinical investigation is about six months.

CONDITIONS

Brief Title

Evaluation of the Performance and Safety of the MD60000 Device in the Treatment of Skin Imperfections Due to Aging.

Research Team

G

Grazia Iannacci

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here